TNF-α is an attractive target for the development of anti-inflammatory drugs because it is an important mediator in the pathogenesis of several inflammatory diseases, including RA, Crohn ̓s disease and ankylosing spondylitis. This evidence concerns the gene TNF and Crohn disease.